Methemoglobinemia: The 'Blue' Patient

If you're like me, methemoglobinemia is one of those conditions where the clinical picture is striking and the diagnosis is initially baffling. The patient looks cyanotic, the blood is chocolate-brown, and the pulse oximeter reads 85% — but no matter how much oxygen you give, it won't budge. On the anesthesiology oral boards, methemoglobinemia is a recognition question and a treatment question. Get either wrong and you're stuck in a logic probe that ends badly.

The most common perioperative causes are benzocaine (used for awake intubation topicalization, TEE probe placement, and endoscopy) and prilocaine (used in EMLA cream and some regional techniques). Any oxidizing drug can theoretically cause it — dapsone, nitrites, certain antibiotics — but benzocaine is the high-yield answer for the OR.

The Core Logic

Normal hemoglobin has iron in the ferrous (Fe2+) state, which can bind oxygen. Methemoglobin has iron in the ferric (Fe3+) state, which cannot. Oxidizing drugs convert Fe2+ to Fe3+ faster than the body's natural reducing mechanisms (primarily NADH-cytochrome b5 reductase) can reverse it. When methemoglobin levels exceed 20-30%, the oxygen-carrying capacity is significantly compromised and symptoms appear.

The pulse oximeter problem: standard pulse oximetry uses only two wavelengths and reads methemoglobin as a mixture of oxyhemoglobin and deoxyhemoglobin. As MetHb levels rise, the reading converges toward 85% regardless of the actual oxygen saturation. This is the "85% ceiling" — a recognizable and specific clue to the diagnosis.

How the Examiner Tests This

Classic scenario: a patient is undergoing a flexible bronchoscopy. Topical benzocaine spray was applied to the cords. Twenty minutes later, the nurse calls you because the SpO2 is 84% and the patient looks dusky. You increase the oxygen. The SpO2 stays at 85%. The examiner pauses.

The key probes: "What's the diagnosis?" Methemoglobinemia — the fixed 85% reading unresponsive to oxygen is the tell. "How do you confirm it?" Co-oximetry from an arterial blood gas, which directly measures MetHb levels. "What do you give?" Methylene blue 1-2 mg/kg IV over 5 minutes.

The Board Trap

The oxygen escalation trap: increasing the FiO2 to 100% and calling for a bag-mask. Supplemental oxygen does not treat methemoglobinemia because the problem is not a lack of inhaled oxygen — the hemoglobin physically cannot bind oxygen. You can intubate the patient and ventilate with 100% O2 and the MetHb levels won't change. The treatment is chemical reduction, not oxygenation.

The G6PD trap: methylene blue works by acting as an electron carrier in the NADPH-dependent methemoglobin reduction pathway. In patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, this pathway is non-functional. Methylene blue will not work and could theoretically worsen hemolysis. In G6PD-deficient patients, exchange transfusion is the treatment. The boards may probe you on this specific exception.

Lead-In Phrases

• "A pulse oximeter reading that plateaus around 85% and fails to respond to increasing FiO2 is the classic picture of methemoglobinemia — I will order a co-oximetry ABG immediately to confirm."
• "I will administer methylene blue 1-2 mg/kg IV over 5 minutes — this acts as an electron donor in the NADPH-dependent reduction pathway, converting ferric iron back to ferrous and restoring oxygen-carrying capacity."
• "If the patient has G6PD deficiency, methylene blue will not be effective — I will consult hematology and consider exchange transfusion or hyperbaric oxygen as alternatives."
• "The most likely culprit in this perioperative context is benzocaine topical spray — I will note this and ensure it is documented as a drug to avoid in future procedures."
• "Supplemental oxygen is supportive but does not treat the underlying problem — increasing the FiO2 does not reduce methemoglobin levels and should not delay methylene blue administration."

FAQs

How quickly does methylene blue work?

Response is typically rapid — MetHb levels begin to fall within 15-30 minutes of administration, and the pulse oximeter reading should start to improve soon after. If there's no response within 30-60 minutes, consider whether the diagnosis is correct, whether the dose was adequate (can repeat up to a total of 7 mg/kg), or whether G6PD deficiency may be preventing the drug from working.

Does methylene blue interfere with pulse oximetry?

Yes — methylene blue is itself a blue dye that transiently interferes with pulse oximetry, causing a false drop in the SpO2 reading immediately after administration. This is expected and should not be interpreted as clinical deterioration. Use clinical assessment and co-oximetry rather than pulse oximetry to monitor the response to treatment.

What MetHb level requires treatment?

Asymptomatic patients with MetHb levels under 20% can often be managed with supplemental oxygen and removing the offending drug. Symptomatic patients (dyspnea, confusion, chest pain) or any patient with MetHb above 25-30% should receive methylene blue regardless of symptoms. Cardiac or pulmonary compromise lowers the threshold for treatment.

Methemoglobinemia is one of the most satisfying board scenarios because the diagnosis is specific (the 85% ceiling) and the treatment is specific (methylene blue). Practice the recognition and treatment sequence in Boards Bot until the benzocaine-to-methylene-blue connection is a reflex.